β2-and β1-adrenoceptor expression exhibits a common regulatory pattern with GRK2 and GRK5 in human and animal models of cardiovascular diseases

Journal of Cardiovascular Pharmacology

Volumn 66, Issue 5, 2015, Pages 478-486

  Montó, Fermí ^a   Oliver, Eduardo ^a   Vicente, Diana ^a   Buendía, Francisco ^b   Rueda, Joaquín ^b   Agüero, Jaime ^b   Almenar, Luis ^b   Valldecabres, Carmen ^c   Rovira, Eduardo ^c   Muedra, Vicente ^c   Noguera, María A ^a   Ivorra, María D ^a   D'Ocon, Pilar ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c HOSPITAL DE LA RIBERA   (Spain)

Author keywords

Beta adrenoceptors; GRKs; Heart failure; Hypertension

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 5; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; ADRB1 PROTEIN, HUMAN; ADRB1 PROTEIN, RAT; ADRB2 PROTEIN, HUMAN; ADRBK1 PROTEIN, HUMAN; ADRBK1 PROTEIN, RAT; GPRK5 PROTEIN, RAT; GRK5 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR KINASE 3;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; ANTIBODY SPECIFICITY; CASE CONTROL STUDY; CHEMICALLY INDUCED; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEART DISEASE; METABOLISM; WISTAR KYOTO RAT; ANIMAL CELL; BODY WEIGHT; HEART WEIGHT; HUMAN CELL;

ANIMALS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; G-PROTEIN-COUPLED RECEPTOR KINASE 2; G-PROTEIN-COUPLED RECEPTOR KINASE 5; GENE EXPRESSION REGULATION; HEART DISEASES; HUMANS; HYPERTENSION; NG-NITROARGININE METHYL ESTER; ORGAN SPECIFICITY; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER;

EID: 84947061009     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000299     Document Type: Article

References (56)

1. Flacco N, Segura V, Perez-Aso M, et al. Different b-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels. Br J Pharmacol. 2013;169:413-425.
2. Penela P, Murga C, Ribas C, et al. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc Res. 2006;69:46-56.
3. Belmonte SL, Blaxall BC. G protein coupled receptor kinases as therapeutic targets in cardiovascular disease. Circ Res. 2011;109:309-319.
4. Sato PY, Chuprun JK, Schwartz M, et al. The evolving impact of Gprotein coupled receptor kinases in cardiac health and disease. Physiol Rev. 2015;95:377-404.
5. Brinks HL, Eckahrt AD. Regulation of GPCR signaling in hypertension. Biochim Biophys Acta. 2010;1802:1268-1275.
6. Agüero J, Almenar L, D'Ocon P, et al. Myocardial and peripheral lymphocytic transcriptomic dissociation of beta-adrenoceptors and G protein coupled receptor kinases in heart transplantation. J Heart Lung Transplant. 2009;28:1166-1171.
7. Montó F, Oliver E, Vicente D, et al. Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure etiology and correlates to clinical variables. Am J Physiol Heart Circ Physiol. 2012;303:H368-H376.
8. Harris DM, Cohn HI, Pesant S, et al. GPCR signaling in hypertension: role of GRKs. Clin Sci. 2008;115:79-89.
9. Brinks HL, Koch WJ. Targeting G protein-coupled receptor kinases (GRKs) in heart failure. Drug Discov Today Dis Mech. 2010;7:e129-e134.
10. Gurevich EV, Tesmer JJG, Mushegian A, et al. G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther. 2012;133:40-69.
11. Rengo G, Lymperopoulos A, Leosco D, et al. GRK2 as a novel gene therapy target in heart failure. J Mol Cell Cardiol. 2011;50:785-792.
12. Penela P, Ribas C, Mayor F. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal. 2003;15:973-981.
13. Ramos-Ruiz R, Penela P, Penn RB, et al. Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter. Regulation by signal transduction systems in aortic smooth muscle cells. Circulation. 2000;101:2083-2089.
14. Hansen JL, Theilade J, Aplin M, et al. Role of G-protein-coupled receptor kinase 2 in the heart-do regulatory mechanisms open novel therapeutic perspectives? Trends Cardiovasc Med. 2006;16:169-177.
15. Salim S, Standifer KM, Eikenburg DC. Extracellular signal-regulated kinase 1/2-mediated transcriptional regulation of G-protein-coupled receptor kinase 3 expression in neuronal cells. J Pharmacol Exp Ther. 2007;321:51-59.
16. Agüero J, Almenar L, D'Ocon P, et al. Correlation between betaadrenoceptors and G-protein-coupled receptor kinases in pretransplantation heart failure. Transplant Proc. 2008;40:3014-3016.
17. Oliver E, Flacco N, Arce C, et al. Changes in adrenoceptors and Gproteincoupled receptor kinase 2 in L-NAME-induced hypertension compared to spontaneous hypertension in rats. J Vasc Res. 2014;51:209-220.
18. Oliver E, Rovira E, Monto F, et al. Beta-adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion. J Hypertens. 2010;28:1281-1289.
19. Vicente D, Montó F, Oliver E, et al. Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: relationship to clinical status. Life Sci. 2013;93:108-115.
20. Pitcher JA, Freedman NJ, Lefkovitz RJ. G protein-coupled receptor kinases. Annu Rev Biochem. 1998;67:653-692.
21. Rockman HA, Choi DJ, Rahman NU, et al. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc Natl Acad Sci U S A. 1996;93:9954-9959.
22. Eckhart AD, Duncan SJ, Penn RB, et al. Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart. Circ Res. 2000;86:43-50.
23. Iaccarino G, Rockman HA, Shotwell KF, et al, Koch, WJ. Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. Am J Physiol. 1998;275:H1298-H1306.
24. Vinge LE, Andressen KW, Attramadal T, et al. Substrate specificities of Gprotein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function. Mol Pharmacol. 2007;72:582-591.
25. Vinge LE, Von Lueder TG, Aasum E, et al. Cardiac-restricted expression of the carboxyl-terminal fragment of GRK3 uncovers distinct functions of GRK3 in regulation of cardiac contractility and growth: GRK3 controls cardiac alpha1-adrenergic receptor responsiveness. J Biol Chem. 2008;283:10601-10610.
26. Hurle MA. Changes in the expression of G protein-coupled receptor kinases andbeta-arrestin 2 in rat brain during opioid tolerance and supersensitivity. J Neurochem. 2001;77:486-492.
27. Diaz A, Pazos A, Florez J, et al. Regulation of mu-opioid receptors, Gproteincoupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism. Neuroscience. 2002;112:345-353.
28. Fan X, Zhang J, Zhang X, et al. Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain. Neuropharmacology. 2002;43:809-816.
29. Oyama N, Urasawa K, Kaneta S, et al. Angiotensin converting enzyme inhibitors attenuated the expression of G-protein coupled receptor kinases in heart failure patients. Circ J. 2006;70:362-363.
30. Rubino T, Viganò D, Premoli F, et al. Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade. Mol Neurobiol. 2006;33:199-213.
31. Schroeder JA, McCafferty MR, Unterwald EM. Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration. Synapse. 2009;63:863-870.
32. Bezard E, Gross CE, Qin L, et al. L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. Neurobiol Dis. 2005;18:323-335.
33. Ahmed MR, Gurevich VV, Dalby KN, et al. Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and ERK activation. J Pharmacol Exp Ther. 2008;325:276-283.
34. Ungerer M, Bohm M, Elce JS, et al. Altered expression of betaadrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993;87:454-463.
35. Ungerer M, Parruti G, Bohm M, et al. Expression of betaarrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res. 1994;74:206-213.
36. Ungerer M, Kessebohm K, Kronsbein K, et al. Activation of betaadrenergic receptor kinase during myocardial ischemia. Circ Res. 1996;79:455-460.
37. Dzimiri N, Basco C, Moorji A, et al. Characterization of lymphocyte beta 2-adrenoceptor signalling in patients with left ventricular volume overload disease. Clin Exp Pharmacol Physiol. 2002;29:181-188.
38. Dzimiri N, Muiya P, Andres E, et al. Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases. Eur J Pharmacol. 2004;489:167-177.
39. Iaccarino G, Barbato E, Cipolletta E, et al. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J. 2005;26:1752-1758.
40. Agüero J, Almenar L, Montó F, et al. Myocardial G protein receptorcoupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure. J Card Fail. 2012;18:53-61.
41. Rockman HA, Chien KR, Choi DJ, et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene targeted mice. Proc Natl Acad Sci U S A. 1998;95:7000-7005.
42. Anderson KM, Eckhart AD, Willette RN, et al. The myocardial betaadrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension. 1999;33:402-407.
43. Iaccarino G, Keys JR, Rapacciuolo A, et al. Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors. J Am Coll Cardiol. 2001;38:534-540.
44. Harding VB, Jones LR, Lefkowitz RJ, et al. Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci U S A. 2001;98:5809-5814.
45. Vinge LE, Oie E, Andersson Y, et al. Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. Am J Physiol Heart Circ Physiol. 2001;281:H2490-H2499.
46. Petrofski JA, Koch WJ. The beta-adrenergic receptor kinase in heart failure. J Mol Cell Cardiol. 2003;35:1167-1174.
47. Choi DJ, Koch WJ, Hunter JJ, et al. Mechanism of betaadrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J Biol Chem. 1997;272:17223-17229.
48. Hata JA, Williams ML, Schroder JN, et al. Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. J Card Fail. 2006;12:360-368.
49. Akhter SA, D'Souza KM, Malhotra R, et al. Reversal of impaired myocardial beta-adrenergic receptor signaling by continuous-flow left ventricular assist device support. J Heart Lung Transplant. 2010;29:603-609.
50. Xiao RP, Zhu W, Zheng M, et al. Subtype-specific beta adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci. 2004;25:358-365.
51. Xiao RP, Zhu W, Zheng M, et al. Subtype-specific alpha1-and betaadrenoceptor signalling in the heart. Trends Pharmacol Sci. 2006;27:330-337.
52. Zhu W, Zeng X, Zheng M, et al. The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. Circ Res. 2005;97:507-509.
53. Port JD, Bristow MR. Altered beta-adrenergic receptor gene regulation and signalling in chronic heart failure. J Mol Cell Cardiol. 2001;33:887-905.
54. Brodde OE, Kretsch R, Ikezono K, et al. Reidemeister JC Human betaadrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. Science. 1986;231:1584-1585.
55. Gros R, Chorazyczewski J, Meek MD, et al. G-Protein-coupled receptor kinase activity in hypertension. Increased vascular and lymphocyte Gprotein receptor kinase-2 protein expression. Hypertension. 2000;35:38-42.
56. Oyama N, Urasawa K, Kaneta S, et al. Chronic adrenergic receptor stimulation enhances the expression of G-protein coupled receptor kinases, GRK2 and GRK5, in both the heart and peripheral lymphocytes. Circ J. 2005;69:987-990.